Ultrafast tyrosine-based cell membrane modification via diazonium salts: A new frontier for biomedical applications
Open Access
- 5 February 2026
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 196, 119095
Abstract
No abstract availableKeywords
All Related Versions
Funding Information
- Centre National de la Recherche Scientifique
- Centre Hospitalier Universitaire de Bordeaux
- Université de Nantes (UAR 3556)
- Labex
- Institut National de la Santé et de la Recherche Médicale
- Agence Nationale de la Recherche (ANR-11-LABX-0016-01)
This publication has 37 references indexed in Scilit:
- Advancements and challenges in developing in vivo CAR T cell therapies for cancer treatmentEBioMedicine, 2024
- The interplay between cytokines, inflammation, and antioxidants: mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compoundsBiomedicine & Pharmacotherapy, 2024
- Novel chemical tyrosine functionalization of adeno-associated virus improves gene transfer efficiency in liver and retinaBiomedicine & Pharmacotherapy, 2024
- Biomaterial-Mediated Exogenous Facile Coating of Natural Killer Cells for Enhancing Anticancer Efficacy toward Hepatocellular CarcinomaBioconjugate Chemistry, 2023
- Protocol Considerations for In Vitro Metabolic Glycoengineering of Non‐Natural GlycansCurrent Protocols, 2023
- The principles and applications of avidin-based nanoparticles in drug delivery and diagnosisJournal of Controlled Release, 2017
- Cytokine secretion in macrophages and other cells: Pathways and mediatorsImmunobiology, 2009
- Autologous and allogeneic HLA KIR ligand environments and activating KIR control KIR NK‐cell functionsEuropean Journal of Immunology, 2008
- A radioactive label for the erythrocyte membraneBiochimica et Biophysica Acta (BBA) - Biomembranes, 1971
- Sulfanilic acid diazonium salt: A label for the outside of the human erythrocyte membraneBiochimica et Biophysica Acta (BBA) - Biomembranes, 1969